查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612234

人工软骨植入市场：按类型、最终用户划分 - 2025-2030 年全球预测

Artificial Cartilage Implant Market by Type (Lower Extremity Joints, Upper Extremity Joints, Vertebral Joints), End-User (Ambulatory Surgery Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，人工软骨植入市场价值为1.1822亿美元，预计2024年将达到1.3579亿美元，复合年增长率为15.37%，预计到2030年将达到3.2169亿美元。

人工软骨植入市场包括用于替代或支撑受损软骨的合成软骨植入物，目的是恢復关节功能并减轻患有骨关节炎和外伤等疾病的患者的疼痛，涉及材料开发和商业化。这些植入对于改善生活品质至关重要，特别是对于更容易出现关节退化的老年人和运动员。应用主要针对膝关节、髋关节和踝关节的修復，对肩关节和肘关节等特殊区域的兴趣日益浓厚。最终使用者包括整形外科诊所、医院、门诊手术中心等。推动市场成长要素包括生物材料的进步、关节疾病盛行率的增加以及微创手术技术的创新。此外，不断增长的医疗保健支出和对关节保护选择的认识进一步提振了市场。潜在的机会在于开发耐用且生物相容的产品，服务于不断发展的运动医学领域，以及增加在医疗需求未被满足的新兴经济体中的存在。然而，高成本、监管障碍和有限的报销方案等挑战可能会限制市场成长。此外，植入排斥的风险以及复製天然软骨的复杂成分所涉及的技术困难可能会抑制快速进展。为了实现业务成长，我们应该专注于奈米技术创新，以提高植入的机械性能和组织完整性。对再生医学的进一步研究，例如将干细胞疗法与人工植入结合，显示出一条充满希望​​的前进道路。该市场竞争激烈，主要参与者在研发方面投入巨资，并透过针对患者的设计和使用寿命等功能使自己脱颖而出。生物技术公司和研究机构之间的合作可以加强产品平臺并扩大市场范围。为了利用当前趋势，公司应专注于病患教育，与医疗保健提供者建立强大的伙伴关係，并确保其产品符合不断变化的临床需求和监管环境。

主要市场统计
基准年[2023] 11822万美元
预测年份 [2024] 1.3579亿美元
预测年份 [2030] 3.2169亿美元
复合年增长率（%） 15.37%

市场动态：快速发展的人工植入市场的关键市场洞察

供需的动态交互作用正在改变人工软骨植入市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 膝骨关节炎和腕骨盛行率增加
    • 人们对人工软骨植入的认识不断增强
    • 医疗支出的增加和医疗设施的进步
  • 市场限制因素
    • 人工软骨和关节关节重建手术的高成本
  • 市场机会
    • 植入材料和手术技术的技术进步
    • 开发用于製造人工软骨植入的智慧技术和3D列印技术
  • 市场挑战
    • 人工软骨植入相关的併发症因素

波特五力：驾驭人工软骨植入市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解人工软骨植入市场的外部影响

外部宏观环境因素在塑造人工软骨植入市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解人工软骨植入市场的竞争状况

对人工植入市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵人工软骨植入市场供应商的绩效评估

FPNV 定位矩阵是评估人工软骨植入市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划人工软骨植入市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人工植入市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 膝关节和腕掌骨骨关节炎的盛行率增加
      • 人们对人工软骨植入的认识不断增强
      • 不断上涨的医疗费用和先进的医疗设施
    • 抑制因素
      • 人工软骨和置换手术的高成本
    • 机会
      • 植入材料和手术技术的技术进步
      • 开发用于生产人工软骨植入的智慧和3D列印技术
    • 任务
      • 与人工软骨植入相关的併发症
  • 市场区隔分析
    • 类型：由于骨关节炎高发生，下肢关节的需求增加人工软骨植入
    • 最终用户：大型患者照护机构对医院人工软骨植入的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人工软骨植入市场：依类型

  • 下肢关节
  • 上肢关节
  • 脊椎骨关节

第七章人工软骨植入市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院

第八章北美和南美人工植入市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区人工植入市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲人工软骨植入市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 瑞士大学资助 1,300 万美元开始膝关节假体试验
    • Sparta 加强 Olumi植入的专利保护
    • CartiHeal 宣布在美国推出第一个 Agili-C商业性植入
  • 战略分析和建议

公司名单

  • Anika Therapeutics, Inc.
  • BioPoly, LLC
  • CartiHeal, Inc. by Smith & Nephew PLC
  • CytoSeek Limited
  • Medtronic PLC
  • Narang Medical Limited
  • NUsurface
  • Orthox Ltd.
  • Sartorius CellGenix GmbH
  • Sparta Biomedical Inc.
  • Stryker Corporation
  • Uteshiya Medicare
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-351BAD503B27

The Artificial Cartilage Implant Market was valued at USD 118.22 million in 2023, expected to reach USD 135.79 million in 2024, and is projected to grow at a CAGR of 15.37%, to USD 321.69 million by 2030.

The artificial cartilage implant market involves the development and commercialization of synthetic materials used to replace or support damaged cartilage, aiming to restore joint functionality and alleviate pain in patients suffering from conditions like osteoarthritis or traumatic injuries. These implants are crucial for enhancing life quality, especially for aging populations and athletes prone to joint degradation. Applications primarily target knee, hip, and ankle repairs, with growing interest in specialized areas like shoulder and elbow joints. End-users include orthopedic clinics, hospitals, and ambulatory surgical centers. Key growth factors driving the market include advancements in biomaterials, increasing prevalence of joint disorders, and technological innovations in minimally invasive surgical techniques. Additionally, rising healthcare expenditure and awareness around joint preservation alternatives further propel the market. Potential opportunities lie in developing enhanced products with greater durability and bio-compatibility, catering to the expanding sports medicine field, and increasing presence in emerging economies with unmet medical needs. However, challenges such as high costs, regulatory hurdles, and limited reimbursement scenarios could temper market growth. Moreover, the risk of implant rejection and the technical difficulties associated with replicating natural cartilage's complex composition may deter rapid advancement. For business growth, the market should focus on innovations in nanotechnology to improve implants' mechanical properties and tissue integration. Further research into regenerative medicine, like stem cell therapy combined with artificial implants, presents promising avenues. The market's nature is highly competitive, with key players investing heavily in R&D to differentiate their offerings through features like patient-specific designs and improved longevity. Collaborations between biotech firms and research institutions can enhance product pipelines and broaden market reach. To capitalize on current trends, businesses should emphasize patient education and forge strong partnerships with healthcare providers, ensuring their products align with evolving clinical needs and regulatory landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 118.22 million
Estimated Year [2024] USD 135.79 million
Forecast Year [2030] USD 321.69 million
CAGR (%) 15.37%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
    • Rising awareness regarding artificial cartilage implants
    • Growing healthcare expenditure and advanced healthcare facilities
  • Market Restraints
    • High cost associated with the artificial cartilage and replacement surgeries
  • Market Opportunities
    • Technological advancements in implant materials and surgical techniques
    • Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
  • Market Challenges
    • Complications factors associated with artificial cartilage implants

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Cartilage Implant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Cartilage Implant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Cartilage Implant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Cartilage Implant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Cartilage Implant Market

A detailed market share analysis in the Artificial Cartilage Implant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Cartilage Implant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Cartilage Implant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Cartilage Implant Market

A strategic analysis of the Artificial Cartilage Implant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Cartilage Implant Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., BioPoly, LLC, CartiHeal, Inc. by Smith & Nephew PLC, CytoSeek Limited, Medtronic PLC, Narang Medical Limited, NUsurface, Orthox Ltd., Sartorius CellGenix GmbH, Sparta Biomedical Inc., Stryker Corporation, Uteshiya Medicare, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Cartilage Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Lower Extremity Joints, Upper Extremity Joints, and Vertebral Joints.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
      • 5.1.1.2. Rising awareness regarding artificial cartilage implants
      • 5.1.1.3. Growing healthcare expenditure and advanced healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the artificial cartilage and replacement surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in implant materials and surgical techniques
      • 5.1.3.2. Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Complications factors associated with artificial cartilage implants
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for lower extremity joints artificial cartilage implant owing to the high prevalence of osteoarthritis
    • 5.2.2. End-User: Rising demand for artificial cartilage implants in hospitals for extensive patient care facilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Cartilage Implant Market, by Type

  • 6.1. Introduction
  • 6.2. Lower Extremity Joints
  • 6.3. Upper Extremity Joints
  • 6.4. Vertebral Joints

7. Artificial Cartilage Implant Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Artificial Cartilage Implant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Cartilage Implant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Cartilage Implant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Swiss university launches artificial knee trial backed by USD 13 million
    • 11.3.2. Sparta strengthens patent protection for Ormi implant
    • 11.3.3. CartiHeal Announces First Commercial Implantation of Agili-C in the US
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics, Inc.
  • 2. BioPoly, LLC
  • 3. CartiHeal, Inc. by Smith & Nephew PLC
  • 4. CytoSeek Limited
  • 5. Medtronic PLC
  • 6. Narang Medical Limited
  • 7. NUsurface
  • 8. Orthox Ltd.
  • 9. Sartorius CellGenix GmbH
  • 10. Sparta Biomedical Inc.
  • 11. Stryker Corporation
  • 12. Uteshiya Medicare
  • 13. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL CARTILAGE IMPLANT MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY LOWER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY UPPER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY VERTEBRAL JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023